| 1 | MALMQVIST J, SIERSMA V, BANG C W, et al.. Consequences of screening in cervical cancer: development and dimensionality of a questionnaire[J]. BMC Psychol., 2021, 9(1): 7-22. | 
																													
																							| 2 | 杜巧红, 吴瑞丽, 廉莉. 全面护理干预在80例宫颈癌放疗患者中的应用观察[J]. 中国药物与临床, 2019, 19(10): 1730-1732. | 
																													
																							| 3 | KUMAR L, HARISH P, MALIK P S, et al.. Chemotherapy and targeted therapy in the management of cervical cancer[J]. Curr. Probl. Cancer., 2018, 42(2): 120-128. | 
																													
																							| 4 | KENMOTSU H, YAMAMOTO N, YAMANAKA T, et al.. Randomized phase Ⅲstudy of pemetrexed plus cisplatin versus vinorelbine plus cisplatin for completely resected stage Ⅱto ⅢA nonsquamous non-small-cell lung cancer[J]. J. Clin. Oncol., 2020, 38(19): 2187-2196. | 
																													
																							| 5 | TALIB W H. Synergistic effect of thymoquinone and melatonin against breast cancer implanted in mice[J]. J. Cancer Res. Thera., 2018, 14(1): 324-329. | 
																													
																							| 6 | ZOU Z W, LIU T, LI Y, et al.. Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS[J]. Redox. Biol., 2018, 16(8): 226-236. | 
																													
																							| 7 | ZHENG H F, KYUNG H J, HONG H Y, et al.. Melatonin synergizes with sorafenib to suppress pancreatic cancer via melatonin receptor and PDGFR-β/STAT3 pathway[J]. Cell Physiol. Biochem., 2018, 4(5)1751-1768. | 
																													
																							| 8 | YU Z, TIAN X, PENG Y, et al.. Mitochondrial cytochrome P450 (CYP) 1B1 is responsible for melatonin‐induced apoptosis in neural cancer cells[J]. J. Pin. Res., 2018, 5(5): 12478-12485. | 
																													
																							| 9 | HUANG L L, RAO W. SiRNA interfering STAT3 enhances DDP sensitivity in cervical cancer cells[J]. Eur. Rev. Med. Pharmacol. Sci., 2018, 22(13): 4098-4106. | 
																													
																							| 10 | 杜春双, 王帅, 张飞,等. 左旋紫草素联合顺铂对宫颈癌Hela细胞的抑制作用及其作用机制[J]. 沈阳药科大学学报, 2018, 35(3): 232-237. | 
																													
																							| 11 | JIN Y, LV L, NING S X, et al.. The anti-tumor activity and mechanisms of rLj-RGD3 on human laryngeal squamous carcinoma Hep2 Ccells[J]. Anticancer Agents. Med. Chem., 2019, 19(17): 2108-2119. | 
																													
																							| 12 | ZIŃCZUK J, ZARĘBA Z, GUZIŃSKA-USTYMOWICZ K, et al.. Expression of chosen cell cycle and proliferation markers in pancreatic intraepithelial neoplasia[J]. Prz. Gastroenterol., 2018, 13(2): 118-126. | 
																													
																							| 13 | 杨松, 魏风, 刘海峰. 颅内良性脑膜瘤全切术后复发的临床病理特征及血管内皮生长因子、细胞周期相关核抗原Ki-67抗体和p53的表达分析[J]. 中国肿瘤临床与康复, 2019, 26(4): 436-438. | 
																													
																							| 14 | 严立冬, 桂卉, 杨卓顺, 等. 上调细胞周期相关蛋白-1的表达对脑胶质瘤U251细胞的增殖和迁移能力的影响[J]. 医学研究生学报, 2018,31(1): 13-18. | 
																													
																							| 15 | CARDANO M, TRIBIOLI C, PROSPERI E. Targeting proliferating cell nuclear antigen (PCNA) as an effective strategy to inhibit tumor cell proliferation[J]. Curr. Cancer Drug Targets, 2020, 20(4): 240-252. | 
																													
																							| 16 | LIU H, GUO D, SHA Y, et al.. ANXA7 promotes the cell cycle, proliferation and cell adhesion-mediated drug resistance of multiple myeloma cells by up-regulating CDC5L[J]. Aging (Albany NY), 2020, 12(11): 11100-11115. | 
																													
																							| 17 | 王彦秋. 冬凌草甲素联合顺铂对宫颈癌SiHa细胞凋亡及FOXL2、Ki67表达的影响[J]. 实用药物与临床, 2018, 21(5): 502-507. | 
																													
																							| 18 | 黄鹏翀, 李晨辉, 王焱. 氟尿嘧啶植入剂对宫颈癌Hela细胞增殖和凋亡的影响[J]. 癌症进展, 2019, 17(11): 1275-1278. | 
																													
																							| 19 | 陈萌萌, 王芳, 潘渊婷,等. 兔源抗凋亡蛋白Bcl-2的表达,抗体的制备及初步应用[J]. 江苏农业学报, 2019, 35(6): 1397-1401. | 
																													
																							| 20 | 石金凤, 罗尧尧, 李佳鑫,等. 雷公藤甲素单用及联合用药抗肿瘤的作用及机制研究进展[J]. 中国中药杂志, 2019,44(16): 3391-3398. | 
																													
																							| 21 | LI Y, LV Z, ZHANG S, et al.. Genetic fate mapping of transient cell fate reveals N-cadherin activity and function in tumor metastasis[J]. Dev. Cell., 2020, 54(5): 593-607. | 
																													
																							| 22 | QUAN Y, ZHANG X, BUTLER W, et al.. The role of N-cadherin/c-Jun/NDRG1 axis in the progression of prostate cancer[J]. Int. J. Biol. Sci., 2021, 17(13): 3288-3304. | 
																													
																							| 23 | LI Y, ZHANG T, QIN S, et al.. Effects of UPF1 expression on EMT process by targeting E‑cadherin, N‑cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line[J]. Mol. Med. Rep., 2019, 19(3): 2137-2143. | 
																													
																							| 24 | 沈庆林, 彭敏, 章必成,等. 微小RNA-138通过调控上皮间质转化抑制乳腺癌侵袭和迁移的机制研究[J]. 中国医师进修杂志, 2019, 42(1): 42-46. |